Rigel Pharmaceuticals (NASDAQ: RIGL) revenue
Rigel Pharmaceuticals reported revenue of $294.3m for fiscal 2025, 64.1% more than in fiscal 2024 ($179.3m). Since fiscal 2016 its revenue has grown by 1,343.8%, an average growth of 34.5% a year.
Rigel Pharmaceuticals has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2017, −78.0%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $294.3m | +64.1% | $125.5m | 42.6% |
| 2024 | $179.3m | +53.4% | $24.2m | 13.5% |
| 2023 | $116.9m | −2.8% | −$20.5m | −17.5% |
| 2022 | $120.2m | −19.4% | −$55.6m | −46.2% |
| 2021 | $149.2m | +37.4% | −$12.5m | −8.4% |
| 2020 | $108.6m | +83.2% | −$29.0m | −26.7% |
| 2019 | $59.3m | +33.2% | −$69.1m | −116.5% |
| 2018 | $44.5m | +892.6% | −$72.7m | −163.3% |
| 2017 | $4.5m | −78.0% | −$79.6m | −1,775.6% |
| 2016 | $20.4m | — | −$69.7m | −342.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Rigel Pharmaceuticals revenue compared with its sector
By revenue for its latest fiscal year, Rigel Pharmaceuticals ranks 222nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Rigel Pharmaceuticals, 64.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 220th | Evolus | $297.2m | 11.6% |
| 221st | Ironwood Pharmaceuticals | $296.2m | −15.7% |
| 222nd | Rigel Pharmaceuticals | $294.3m | 64.1% |
| 223rd | Xeris Biopharma | $291.8m | 43.7% |
| 224th | Aurinia Pharmaceuticals | $283.1m | 20.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Rigel Pharmaceuticals
- How much revenue did Rigel Pharmaceuticals make in fiscal 2025?
- Rigel Pharmaceuticals reported revenue of $294.3m for fiscal 2025, compared with $179.3m in fiscal 2024.
- How much has the revenue of Rigel Pharmaceuticals grown?
- Between fiscal 2016 and fiscal 2025 it went from $20.4m to $294.3m: 1,343.8% more, an average growth of 34.5% a year.
- What was the best year for revenue at Rigel Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2025, with $294.3m.
- Where does Rigel Pharmaceuticals rank in its sector by revenue?
- It ranks 222nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Rigel Pharmaceuticals come from?
- From the annual report (Form 10-K) that Rigel Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Rigel Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Rigel Pharmaceuticals: the Rigel Pharmaceuticals page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.